chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a physician referring to an infant patient of unknown age. Information regarding pertinent medical history, drug reactions or allergies or concomitant medication was unknown. On an unknown date, the patient was vaccinated with an unspecified number of doses of PNEUMOVAX 23 for prophylaxis (route and lot number were not informed). On an unknown date, the patient developed seizures. The physician stated that "the defending plaintiff was saying that harm was done to an infant and it was initiated by phospholipids in the vaccine". At the time of reporting, the outcome of seizure was unknown. The reporter considered seizure to be related to PNEUMOVAX 23. Upon internal review the event seizure was determined to be medically significant.
The patient's son contacted the pharmacy approximately 1 hour post vaccination and reported numbness in the left hand and tingling along the left arm. The patient's son contacted the pharmacy approximately 2 hours after the initial report of adverse reactions and stated that both the tingling and numbness had resolved.
The reaction started on Wednesday morning May 19 around 7:00a.m. Vomiting, diarreaha  Fainted 3 times vomited again fever 103.2. Slept until the next morning couldn?t keep anything down fainted again. Gave Gatorade  Propell and water. Very fatigued  couldn?t walk at all. Very dizzy no color on his face very pale lol
103 TEMPERATURE, SHIVERING CHILLS ALL NIGHT, RAPID HEARTBEAT, BODY ACHES THAT CAUSED IMMOBILIZATION, SEVERE HEADACHE
My face is extremely greasy and am breaking out/My hair is also oily which it never is; Face is extremely greasy and am breaking out; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 10:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA), fibromyalgia, pimples when she was 14 and restless leg syndrome (RLS) since unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included tofacitinib citrate (XELJANZ), gabapentin (MANUFACTURER UNKNOWN), duloxetine (MANUFACTURER UNKNOWN) and pantoprazole (MANUFACTURER UNKNOWN); for an unknown indication, from an unknown date and unknown if ongoing. The patient previously took benzoin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 15:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 00:00, the patient experienced extremely greasy face and breaking out. She did not have breakouts since she was 14. The patient got out of the shower and within 10 minutes she felt like she needed to scrub her face again. There had been no changes in any medicine or other health issues other than getting the COVID-19 vaccine. The patient's hair was also oily which it never was. She usually went 3 days between hair washes and reported that since Saturday when this all started, she had to wash her hair every day. The patient was not pregnant and had no menstrual related acne or oiliness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event face was extremely greasy, breakouts and oily hair was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
pt.  recd. vax & developed measles-like rash w/ congestion & cough.
Day of vaccine typical site discomfort on Tuesday by Thursday had tingling in right lower thigh and knee by Sunday quarter size welt inner thigh (right) Monday -saw MD confirmed case of shingles pt believes flu shot caused shingles.
mild nosebleed; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on 26Aug2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced mild nosebleed on Saturday 28Aug2021. Patient stated, and a bad nosebleed today on 30Aug2021. Patient wanted to know that do you have information on it causing nosebleeds. The outcome of event was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be re-quested during follow up.
This spontaneous report was received from an office manager (also reported as healthcare worker) concerning a male patient of unknown age. Approximately on an unknown date in 2013 (reported as over one year ago), the patient was vaccinated with the first dose of GARDASIL (lot number, expiry date, dose and route unspecified) and would be receiving his second dose in the series in the near future. No concomitant medications were reported. No adverse effects were reported. Additional information has been requested.
Patient received FLUVIRIN vaccine on 9/23/2016. Patient reported that she woke up the next morning with a rash on her face. Pt has been using BENADRYL and hydrocortisone cream for the rash.
On Tuesday, October 8 at approximately noon the patient states the injection site was itching, red and warm which covered her shoulder approximately the size of her deltoid muscle.   Additionally, she stated it was bruised.    Wednesday, October 9 at 9:45 a.m. the site had minimal redness was slightly warm to the touch.  Bruising was the size of a half dollar.
The patient experienced severe headache and mental confusion after receiving the influenza vaccines a few days at the November Unit Training Assembly. He and his spouse went to the local Emergency Room, but later was transferred to and admitted to Hospital with diagnosis Acute Disseminated Encephalomyelitis.
Injection site arms feeling heavy & painful for approx 45min.  Fast heart beat & palpitation more than 1 hr. Redness of  my face last for approx hour & half. Feeling tired for two days. On my second week, having pain in my lower  left abdomen.  Severely painful 1st of April check in to ER Chet pain & elevated high blood pressure  Check in Urgent care
104 degree fever at 4:30 pm the day after vaccine administration. Fever was able to be brought down using ibuprofen and Tylenol. A lower fever than 104 degrees persisted for over 80 hours post-vaccination.
Woke up heart racing, flushing/hot flashes.  Able to go back to sleep within an hour but very scary.
Patient reported he developed blood blisters on his 3rd and 4th fingers, and thumb on tuesday on 4/13, and nose bleed,  which resolved on its own.
covid 19 vaccine,on antibiotics for virus infection for  20 days,unexpected miscarriage while on new birthcontrol pill went mentally unstable and fainted mild seizure.Got a toe infection with fever first symptoms
Burning deep red large swollen itching circle around injection site about 5-in long and 4-in wide
extreme sensitivity to light and particularly electronic items; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient in his 70's received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PHOTOPHOBIA (non-serious) with onset 24Jun2022, outcome "unknown", described as "extreme sensitivity to light and particularly electronic items".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Baseball size area of Redness, hot and painful radiates to L shoulder and down L arm.
After, we noticed a change in her behavior. Very fussy. It got increasingly worse. She would stare into space for minutes at a time. We now know these were seizures.  A few weeks later she was diagnosed with infantile spasms.
Right elbow started hurting so much it was difficult to raise my arm to touch my face. Left elbow also hurts but less than right. I waited for symptoms to subside but over a month has passed and there is not much improvement.
Affecting people's hearing ability; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (Affecting people's hearing ability) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOACUSIS (Affecting people's hearing ability). At the time of the report, HYPOACUSIS (Affecting people's hearing ability) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were not reported. No treatment medications were not provided.
Large hive on left upper arm Pinkish rash on left upper arm Itching Just started today 1/19/21
Suspected vaccination failure; Friend got them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient's friend. The age at vaccination was not reported. 2 years after receiving Shingles vaccine, the patient got shingles. The reporter stated that, even after the shot, you could get shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization and laboratory confirmation of shingles were not provided.
Patient had High fever 102, severe swelling of right thigh at injection sight with redness.
Developed pain, redness, decreased ROM, swelling in LUA at site of injection less than 12 hours from TD injection. Redness/warm in circular 6x6 cm pattern at distal deltoid.
Patient had myalgias around 24 hours after vaccine, took some Tylenol that day.  On the second day after the vaccine, he had chest pressure (low grade).  He did not take anything for it, but woke up with worsening chest pain the following morning (3 days post vaccine).  He was taken via EMS to the ER at the Hospital and was found to have elevated inflammatory markers, elevated troponins, and ST changes on EKG (consistent with myocarditis/pericarditis).  He had an ECHO with normal function.  We followed his troponins until they declined (around 7 days post vaccine) and his chest pain resolved.  He was given scheduled ibuprofen during his stay here.  He had no hemodynamic instability or arrhythmias.
Painful arm at injection site.  Continued to pain in gland in left armpit - to become throbing pain overnight and through the next day. Difficulty lifting arm or extneding to pick up items.   Fever, shivers and general muscle pain starting 11:00 pm.  Joint pain in hands, general pain in various areas in muscles.  Skin tenderness on head (slightly painful to the touch).  Unable to sleep until after 7 am following day from injection.  Day 2 still have swollen painful gland in left armpit, other glands slighty swollen but no pain.  Joint stiffnes and slight pain in hands, fever and chills continues but as a lesser severity (severity dropped at about 6:00 am}.  Some 'pings' of pain in forearm and other spots not consistent to spot or type.
Possible four minutes of unresponsive, eyes open. No movement. No GTC. Concerning for seizure.
reactivated chronic ebstein barr virus flare up causing extreme fatigue. Developed hypothyroidism. Hair falling out.
SEIZURE; DIAPHORESIS; PALE; NAUSEOUS; This spontaneous report received from a patient concerned a 27 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included no alcohol use, and non smoker, and other pre-existing medical conditions included patient had no known drug allergies and patient had no drug abuse or illicit drug usage. Patient had no medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: 31-OCT-2021) frequency 1 total, dose was not reported, administered to left arm on 03-JUN-2021 at 14:37 p.m. for prophylactic vaccination.  No concomitant medications were reported.  On 03-JUN-2021, events occurred within 3 minutes post-vaccination- seizure, diaphoresis. After seizure-like activity, patient was nauseated and pale. The reporter began cool compress, BP monitoring (Blood pressure measurement) result not reported, called EMS (emergency medical services), and gave water and snacks. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from seizure, diaphoresis, pale, and nauseous on 03-JUN-2021. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210607494-Covid-19 vaccine ad26.cov2.s-Seizure. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
2/22 Diahrrea 2/23 Widespread body pain, temperature of 105, hard chills,2/24 more pain, dizzyness, sleepiness,night terrors, night sweats, 2/24 & 2/25 extreme soreness all over, internal organs in pain, continued diahrrea, loss of appetite, dehydration, 2/26 weakness, still diahrrea,2/27 retained food for the 1st time. I am still weak, dehydrated & have very black stools.
Fever, dizziness, nausea, stomach pain, vomiting, numbness and pain in arm.
On 12/11, generalized itching began. 12/11 multiple rashes appeared on various parts of body and would come and go within hours. Monday 12/12 patient was seen at urgent care and prescribed oral prednisone and started on famotidine 40mg BID and diphenhydramine 25mg-50mg q 6 hrs PRN. Patient rec'd IM solumedrol on 12/14 and then resumed oral prednisone the following day (prescribed down taper). 12/15 patient woke with hives and throat tightness. Went to ER and given same oral medications as he was taking at home. Began taking cetirizine 10mg qhs as well. Rashes, dermographism continued. Saw PCP on 12/20 and 12/24 with diagnosis of dermatitis (cause at this time had not been determined). Last day of prednisone given on 12/25. On 12/26 patient and family determined that vaccine may be the cause. Got a same day appointment on 12/27 and allergist confirmed that dermographism and hives were an immunologic response (not allergic) and were likely due to booster.   Rashes ranged from dark purple (on back of head) to light pink and raised bumps where clothing touched skin (chest, legs, waistline), etc. Hands pink and swollen at times and some transient "tingling" occurred. Rashes on bottom of feet would come and go, persisted heavily for 3 days and patient described sensation as "walking on rocks."
reported inflammation soreness, and itching at injection site 10/11/19.  reported to pharmacy on 10/14/19 symptoms had subsided considerably
I contracted COVID-19 on 06/30/2022 with symptoms of chest congestion, headache, fatigue, and elevated temperature. My doctor  recommended I  take Claritin, Robitussin, and Tylenol to treat the symptoms. I was ill for 5 days before my symptoms began to resolve. I am still currently experiencing chest congestion, fatigue, but my other symptoms are improving so far.
Myalgia, NauseaVomiting, SORENESS AT INJECTION SITE, DIZZINESS, EXHAUSTION Narrative:
My chest became sensitive to touch. Including between my shoulders, you can't even lightly graze those areas without pain.
The first night I felt fine and had no issues, no temperature, no reaction, no soreness in arm, no bump at vaccine site. Then, about 3-4 days later, I got the feeling that I was catching the flu and my insurance company had sent me a package that had a digital thermometer and prescription of Tamiflu and COVID test and as my temperature began to rise I felt weak and I thought it might be the flu. I called my doctor and he said I should come in and they asked me to come in at 2 PM. She did the nasal and made me wait and 15 minutes later she came and said I have COVID. They checked my oxygen level which was low. They told me to just go home and rest. I left and came home and checked my pulse oxygen level and it was still low but I had no shortness of breath or cough so I just thought I would take a hot shower and breathe in the steam and break whatever it is in my lungs. In the shower I felt like I was going to black out so I got out and took temperature and it was up but it didn't feel accurate. As the evening progressed my temperature continued to climb and I could tell because I was getting the chills. I turned on the heat and still couldn't get warm. Temperature was at 106 and so I called my doctor and they told me to take an ice bath but I didn't have bathtub or an ice maker, so they told me to lie in the snow and I didn't want to because I thought I'd die. I went out and lied in snow and it brought my temperature down 3 degrees. They called back 10-15 minutes later and I talked to the doctor and she told me she was tired of me calling and to go to the hospital so they could deal with me (CO) and hung up. I changed doctors after that. I couldn't get to the hospital because there was a snow storm but the local fire department looked after me and my neighbor who is a heart surgeon looked after me and brought me a 2 liter bottle oxygen and when I called the Dr. she told me to stop taking oxygen so I was done with her, and the heart surgeon neighbor brought me a oxygen concentration which I used for 3 weeks because I did have shortness of breath. I stopped using the oxygen and started exercising and I did go see a pulmonary specialist and they gave me, after an hour of breathing test, albuterol. They wanted a follow up but couldn't go see them because they were with the old office with the first Dr. and not the new Dr. I finally recovered from that and life was good until it was to get the 2nd dose and they asked me about a temperature when I called to confirm 2nd dose appointment and since I did have a temperature I had to wait until I was 10 days fever free.
Information has been received from a physician via company employees and a practice manager referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 31-MAR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5 ml Prefilled Syringe (PFS) (lot # K020795, expiration date 19-MAR-2016, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 16 hours with the lowest recorded temperature of 33 Fahrenheit degree. The total cumulative excursion time of the second time was 64 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
I HAD A 99 DEGREE FEVER ROUGHLY FIVE HOURS AFTER TAKING THE SHOT. I TOOK TYLENOL AND FEVER SUBSIDED.
Muscle pain in her arm / achy with movement; Muscle pain in her arm / achy with movement; This case was reported by a consumer via call center representative and described the occurrence of myalgia in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Tetanus NVS (Tetanus vaccine).   On 3rd March 2020, the patient received the 1st dose of Shingrix. In March 2020, less than a day after receiving Shingrix, the patient experienced myalgia and pain upon movement. In March 2020, the outcome of the myalgia and pain upon movement were recovered/resolved.   It was unknown if the reporter considered the myalgia and pain upon movement to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. within 24 hours of vaccination the patient noticed the muscle pain in her arm, and noted it was even achy with movement.  The symptoms lasted for 3 days and resolved.   The patient also noted a Tetanus shot in the alternate arm on the same day, but only pain in the arm with the shingrix. Did not consent to follow-up.
had both shots and still came down with COVID; had both shots and still came down with COVID; This is a spontaneous report from a contactable consumer reporting for a friend.   A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 and dose 2 both via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose, for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The reporter stated that  her friend had both shots and still came down with COVID.The events outcome was unknown.   Information on the lot/batch number has been requested.
She received an influenza vaccine and several minutes later felt flushed with reddening of skin on chest; then developed pain shooting up her back.  She then felt anxious and hyperventilated resulting in tingling in her hands and developed upper abdominal/lower chest ' pushing' sensation.  She felt light headed as though she was almost ready to lose consciousness.  She now feels well.
PATIENT ARM IS RED AND HOT. PATIENT WENT TO DR. DR STATES PT HAS PHLEBITIS AT INJECTION SITE.
Not great reactions; long COVID; Not great reactions; long COVID; Not great reactions; long COVID; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2023NVX-US-000001072 (Novavax).  A 46-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and in Apr2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), POST-ACUTE COVID-19 SYNDROME (non-serious), outcome "unknown" and all described as "Not great reactions; long COVID".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.